Lovenox and Prohance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Prohance (gadoteridol). Common drug interactions include myalgia among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Lovenox and Prohance. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Prohance?

Prohance has active ingredients of gadoteridol. eHealthMe is studying from 3,734 Prohance users. Check the latest studies of Prohance.

On Jul, 15, 2026

47 people who take Lovenox and Prohance together, and have interactions are studied.

What are the common drug interactions of Lovenox and Prohance, by gender? *:

female:

Myalgia (muscle pain)
Skin discolouration (change of skin colour)
Skin tightness
Joint stiffness
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Deformity (disfigurement)
Gait disturbance
Muscular weakness (muscle weakness)
Arthralgia (joint pain)

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin induration (an abnormally hard spot or area on the skin)
Deformity (disfigurement)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Emotional distress
Muscular weakness (muscle weakness)
Joint contracture (a permanent shortening of a muscle or joint)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Skin exfoliation (removal of the oldest dead skin cells)

What are the common drug interactions of Lovenox and Prohance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Oedema peripheral (superficial swelling)
Pain in extremity
Skin hypertrophy (skin cells enlarges)
Skin tightness
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Joint stiffness

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Myalgia (muscle pain)
Oedema peripheral (superficial swelling)
Adverse event
Deformity (disfigurement)
Erythema (redness of the skin)
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Pain
Pain in extremity

50-59:

Pruritus generalised (generalized itching)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Back disorder
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Burning sensation
Emotional distress
Fall
Hyperaesthesia
Immobile (not moving)
Induration (thickening of tissue)

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Hypoaesthesia (reduced sense of touch or sensation)
Muscle tightness
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Pruritus generalised (generalized itching)
Skin discolouration (change of skin colour)
Skin plaque (red, scaly patches to appear on the skin)
Anxiety
Injury

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 23 people, 48.94%
Pain: 9 people, 19.15%
High Blood Pressure: 6 people, 12.77%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 12.77%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 12.77%
Nausea (feeling of having an urge to vomit): 5 people, 10.64%
Stress And Anxiety: 4 people, 8.51%
Spinal Cord Infection: 4 people, 8.51%
Neuralgia (pain in one or more nerves): 4 people, 8.51%
Pain In Extremity: 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and Prohance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously